Unknown OBSERVATIONAL NCT04710849

Relationship Between Plasma Metabolome and the Efficacy of Systemic Glucocorticoid in AECOPD

Relationship Between Plasma Metabolome and the Efficacy of Systemic Glucocorticoid in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Sponsor: Peking University Third Hospital

Conditions COPD COPD Exacerbation Acute

Interventions Serum metabolic markers

Updated 3 times since 2021 Last updated: Jan 12, 2021 Started: Feb 1, 2021 Primary completion: Feb 1, 2024 Completion: Jun 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates COPD and COPD Exacerbation Acute and is currently ongoing. Peking University Third Hospital leads this study, which shows 3 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Recruiting → Unknown
Feb 2021 — Jul 2024 [monthly]

Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking University Third Hospital

Data source: Peking University Third Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China